Bioavailability of rifampicin following
Selected Abstract
Bioavailability of rifampicin following concomitant administration of ethambutol or isoniazid or pyrazinamide or a combination of the three drugs
Background & Objectives: Poor bioavailability of rifampicin (R) in combination with other anti-tuberculosis drugs such as isoniazid (H), pyrazinamide (Z), and etliambutol (E) is a subject of much concern for the last few decades. This could be due to an interaction between R and other drugs. An ... September 1, 2003; Indian Journal of Medical Research
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Bioavailability of rifampicin following concomitant administration of ethambutol or isoniazid or pyrazinamide or a combination of the three drugs
|
